Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
Widespread resistance towards antimony and reports of relapses following miltefosine treatment has severely affected the management of visceral leishmaniasis (VL) in the Indian subcontinent. Paromomycin (PMM), an aminoglycoside antibiotic, has been licensed for VL treatment in India in 2007. Althoug...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2017-12-01
|
| Ráidu: | International Journal for Parasitology: Drugs and Drug Resistance |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2211320717301069 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|